NantHealth

Delisting of Securities of NantHealth, Inc.; Surgalign Holdings, Inc.; Lordstown Motors Corp.; iMedia Brands, Inc.; Crescera Capital Acquisition Corp.; Better World Acquisition Corp.; Tattooed Chef, Inc.; and Alpine Summit Energy Partners, Inc. from The N

Retrieved on: 
Tuesday, July 25, 2023

Nasdaq also announced today that it will delist the Class A common stock of Lordstown Motors Corp. Lordstown Motors Corp.’s securities were suspended on July 7, 2023, and have not traded on Nasdaq since that time.

Key Points: 
  • Nasdaq also announced today that it will delist the Class A common stock of Lordstown Motors Corp. Lordstown Motors Corp.’s securities were suspended on July 7, 2023, and have not traded on Nasdaq since that time.
  • Nasdaq also announced today that it will delist the Class A common stock, unit, and warrant of Better World Acquisition Corp.
  • Better World Acquisition Corp.’s securities were suspended on July 11, 2023, and have not traded on Nasdaq since that time.
  • Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series .

NantHealth’s Eviti Connect Achieves HITRUST Risk-based, 2-year Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance

Retrieved on: 
Tuesday, March 21, 2023

NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions transforming complex data into actionable insights, today announced its Eviti Connect solution has earned Certified status for information security by HITRUST .

Key Points: 
  • NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions transforming complex data into actionable insights, today announced its Eviti Connect solution has earned Certified status for information security by HITRUST .
  • HITRUST Risk-based, 2-year (r2) Certified status demonstrates that NantHealth’s Eviti Connect solution has met key regulations and industry-defined requirements for managing risk.
  • This achievement places NantHealth in an elite group of organizations worldwide that have earned this certification.
  • “NantHealth’s Eviti Connect HITRUST Risk-based, 2-year Certification is evidence that they are at the forefront of industry best practices for information risk management and compliance.”

NantHealth Announces $22.5 Million New Financing with Highbridge and Nant Capital

Retrieved on: 
Monday, March 6, 2023

The company intends to use the proceeds to continue funding its existing businesses and for general corporate purposes.

Key Points: 
  • The company intends to use the proceeds to continue funding its existing businesses and for general corporate purposes.
  • The Term Loan Facility was funded by two existing NantHealth investors: Highbridge Capital Management, LLC and Nant Capital, LLC.
  • NantHealth has stood at the forefront of driving evidence based, low cost care to treat the right patient at the right time and the right place.
  • We are pleased at the continued support of NantHealth at this transformational time in healthcare,” said Dr. Patrick Soon-Shiong, Chairman and CEO, NantHealth.

OpenNMS releases OpenNMS Meridian 2023 with New Cloud-enabled Capabilities

Retrieved on: 
Wednesday, February 22, 2023

The OpenNMS Group, Inc ., a subsidiary of NantHealth, Inc. (NASDAQ: NH), today announced the release of OpenNMS Meridian 2023 .

Key Points: 
  • The OpenNMS Group, Inc ., a subsidiary of NantHealth, Inc. (NASDAQ: NH), today announced the release of OpenNMS Meridian 2023 .
  • "The cloud capabilities we're launching with Meridian 2023 bring us a huge step closer to our vision of a world where monitoring just happens," said David Hustace, President, Founderat OpenNMS.
  • OpenNMS is also part of the Common Vulnerabilities and Exposures (CVE) system’s Numbering Authorities (CNA) program to augment its CVE reporting capabilities.
  • For more information about OpenNMS Meridian 2023, please visit https://www.opennms.com/meridian/ .

InterVenn Biosciences Enters Next Stage with Senior Management Team Updates Focused on Commercialization

Retrieved on: 
Thursday, January 5, 2023

InterVenn Biosciences, the life science company pioneering glycoproteomics co-founded by Nobel Prize winner Carolyn Bertozzi, PhD, Carlito Lebrilla, Ph.D., and Aldo Carrascoso, today announced changes to its senior management team to support its commercialization execution.

Key Points: 
  • InterVenn Biosciences, the life science company pioneering glycoproteomics co-founded by Nobel Prize winner Carolyn Bertozzi, PhD, Carlito Lebrilla, Ph.D., and Aldo Carrascoso, today announced changes to its senior management team to support its commercialization execution.
  • “From the beginning, Genoa has been on the journey with InterVenn to realize the exceptional potential of glycoproteomics to provide necessary specificity for precision medicine applications.
  • Estigarribia takes on the CEO role at InterVenn as the company’s platform is ready for commercialization.
  • Estigarribia and his team will expand the market applications of the platform as well as the scope of partnering capabilities.

NantHealth Announces 1-for-15 Reverse Stock Split

Retrieved on: 
Thursday, December 15, 2022

The reverse stock split will reduce the number of shares of the companys common stock from approximately 115,550,244 shares to approximately 7,703,350 shares, but will not change the authorized number of shares of common stock, which will remain at 750,000,000 shares.

Key Points: 
  • The reverse stock split will reduce the number of shares of the companys common stock from approximately 115,550,244 shares to approximately 7,703,350 shares, but will not change the authorized number of shares of common stock, which will remain at 750,000,000 shares.
  • In connection with the reverse stock split, the companys CUSIP number will change to 630104305 as of December 15, 2022 at 5 p.m.
  • The reverse stock split will affect all stockholders uniformly and will not alter any stockholders percentage interest in the companys equity, except to the extent that the reverse stock split would result in a stockholder owning a fractional share.
  • Stockholders of record will be receiving information from the companys transfer agent regarding their common stock ownership post-reverse stock split.

NantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3

Retrieved on: 
Monday, October 31, 2022

NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 third quarter on Thursday, November 3, 2022, after market close.

Key Points: 
  • NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 third quarter on Thursday, November 3, 2022, after market close.
  • NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m.
  • The conference call will be available to interested parties by dialing 800-942-2493 from the U.S. or Canada, or 212-231-2931 from international locations.
  • NantHealth, a member of the NantWorks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights.

WellStack Expands Executive Team with Chief Revenue Officer Christopher Rogowski

Retrieved on: 
Tuesday, October 11, 2022

WellStack, a leading provider of healthcare data and analytics solutions, is proud to announce the addition of Christopher Rogowski as Chief Revenue Officer.

Key Points: 
  • WellStack, a leading provider of healthcare data and analytics solutions, is proud to announce the addition of Christopher Rogowski as Chief Revenue Officer.
  • Chris is responsible for building a client-driven organization and will lead WellStacks top line and market share growth opportunities.
  • View the full release here: https://www.businesswire.com/news/home/20221011005191/en/
    Chris Rogowski, Chief Revenue Officer for WellStack (Photo: Business Wire)
    We are glad to have Chris join our growing team and lead our sales operations, noted Ravi Kalla, Founder and CEO for WellStack.
  • WellStack offers healthcare organizations a modern, out-of-the-box data ecosystem that creates a single source of truth necessary for enterprise-wide decision-making.

Pendo Draws 1,000 Attendees to Sixth Annual Pendomonium Festival, Unveils New Product Enhancements to Help Companies Drive Efficient Growth

Retrieved on: 
Thursday, September 15, 2022

RALEIGH, N.C., Sept. 15, 2022 /PRNewswire/ -- Pendo, the most comprehensive product experience platform, today closed out its sixth annual Pendomonium product festival, gathering more than 1,000 product and IT leaders together at Raleigh's Duke Energy Center for the Performing Arts to advance the craft of product management. During the event, themed "The Product-Led Experience", Pendo announced The Pendo Employee Data Privacy Pledge, and a series of new product features and enhancements that allow companies to leverage product-led strategies to help their companies drive efficient growth.

Key Points: 
  • During the event, themed "The Product-Led Experience", Pendo announced The Pendo Employee Data Privacy Pledge, and a series of new product features and enhancements that allow companies to leverage product-led strategies to help their companies drive efficient growth.
  • "This year's Pendomonium taught us how to use our products to weather today's economy and explore the future of product experiences in an increasingly digital world.
  • Pendo also announced the winners of its annual Pendo Customer Awards program , recognizing 11 customers for their use of Pendo to achieve positive business outcomes.
  • Through Mind the Product and customer communities, sponsored events and a podcast, Pendo aims to support the success of product and digital leaders everywhere.

NantHealth’s Eviti Platform Once More Earns Full URAC Accreditation Through 2025

Retrieved on: 
Wednesday, August 24, 2022

This latest recognition extends URAC accreditation through September 1, 2025.

Key Points: 
  • This latest recognition extends URAC accreditation through September 1, 2025.
  • The URAC accreditation process validates compliance with nationally recognized, evidence-based standards and supports improvements and innovation in healthcare management and delivery.
  • "NantHealth is honored to have attained full reaccreditation from URAC for Health Utilization Management," said Ron Louks, NantHealths chief operating officer.
  • URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.